Press Release
August 1, 2012

Good Wins Update

Goodwin Procter’s litigation attorneys have recently delivered key victories on a wide range of complex legal matters for clients including:

Goodwin Procter Successfully Represents Quicken Loans Before U.S. Supreme Court

The United States Supreme Court has ruled unanimously in favor of Goodwin Procter client Quicken Loans in a lawsuit involving interpretation of the Real Estate Settlement Procedures Act (“RESPA”) in a dispute over lending fees.

The court’s decision in Freeman v. Quicken Loans was a substantial victory for Quicken Loans that also has significant implications for the mortgage industry, nullifying multiple suits mortgage settlement service providers have faced over the last decade.

The plaintiffs had argued that RESPA prohibited mortgage providers from charging “unearned fees.” In authoring the court’s opinion, Justice Antonin Scalia disagreed. “Vague notions of statutory purpose provide no warrant for expanding §2607(b)’s prohibition beyond the field to which it is unambiguously limited: the splitting of fees paid for settlement services,” he wrote.

Goodwin Securities Litigators Secure Class Action Win for Private Education Provider

To read more on this case, please click here.

Teva Achieves Major Trial Victory as Goodwin Litigators Defend Copaxone Patent

The U.S. District Court for the Southern District of New York on June 22 ruled in favor of Goodwin Procter clients Teva Pharmaceutical Industries, Teva Pharmaceuticals USA and Teva Neuroscience in a significant patent litigation involving Teva’s brand product, Copaxone®.

The court ruled that Teva’s nine patents were valid, enforceable and infringed by the proposed generic products of defendants Sandoz/Momenta Pharmaceuticals and Mylan/Natco Pharma. Goodwin Procter litigators, together with attorneys from co-counsel Kenyon & Kenyon, tried the case before Judge Barbara Jones in two bench trials in July and September of last year. In its nearly 280-page opinion, the court adopted virtually all of Teva’s positions and found that all 22 of the asserted patent claims were infringed.

To read more on this case, please click here.

Goodwin Appellate Victory Allows Entergy to Continue Operating VT Power Plant

Goodwin attorneys achieved a significant victory on behalf of Entergy Corporation when the U.S. Court of Appeals for the District of Columbia Circuit on June 26 rejected challenges brought by the State of Vermont and outside groups to the Nuclear Regulatory Commission’s grant of Entergy’s 20-year renewed operating license for its Vermont Yankee nuclear power station.

To read more on this case, please click here.

Arbitration Judge Finds in Favor of Goodwin Client Invensys Following Dispute With Distributor

Goodwin Procter client Invensys, a leading supplier of automation software and equipment, recently won an arbitration decision following a dispute with See Plus, a former distributor for the company.

See Plus had brought a claim seeking more than $6 million in damages. The arbitration judge’s Final Award defeated each of See Plus’ legal claims.

To read more about this case, please click here.